1. Farley A, McLafferty E, Hendry C. The cardiovascular system. Nursing standard (Royal College of Nursing (Great Britain). 2012;27(9):35-9.doi: 10.7748/ns2012.10.27.9.35.c9383. [
DOI:10.7748/ns2012.10.27.9.35.c9383]
2. Benjamin EJ, Virani SS, Callaway CW, Chamberlain AM, Chang AR, Cheng S, Chiuve SE, Cushman M, Delling FN, Deo R, De Ferranti SD. Heart disease and stroke statistics-2018 update: a report from the American Heart Association. Circulation. 2018;137(12):e67-492. [
DOI:10.1161/CIR.0000000000000573]
3. Dunbar SB, Khavjou OA, Bakas T, Hunt G, Kirch RA, Leib AR, et al. Projected costs of informal caregiving for cardiovascular disease: 2015 to 2035: a policy statement from the American Heart Association. Circulation. 2018;137(19):e558-77. [
DOI:10.1161/CIR.0000000000000570]
4. Apple FS, Sandoval Y, Jaffe AS, Ordonez-Llanos J. Cardiac troponin assays: guide to understanding analytical characteristics and their impact on clinical care. Clinical chemistry. 2017;63(1):73-81. [
DOI:10.1373/clinchem.2016.255109]
5. Thygesen K, Alpert JS, White HD, Jaffe AS, Apple FS, Galvani M, et al. Universal definition of myocardial infarction. Circulation. 2007;116(22):2634-53. [
DOI:10.1161/CIRCULATIONAHA.107.187397]
6. Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, et al. Fourth Universal Definition of Myocardial Infarction (2018). Circulation. 2018;138(20):e618-e51. [
DOI:10.1161/CIR.0000000000000617]
7. Israel O, Pellet O, Biassoni L, De Palma D, Estrada-Lobato E, Gnanasegaran G, et al. Two decades of SPECT/CT-the coming of age of a technology: an updated review of literature evidence. European journal of nuclear medicine and molecular imaging. 2019;46(10):1990-2012. [
DOI:10.1007/s00259-019-04404-6]
8. Felner JM. An overview of the cardiovascular system. Clinical Methods: The History, Physical, and Laboratory Examinations. 3rd edition. 1990.
9. Hicks KA, Mahaffey KW, Mehran R, Nissen SE, Wiviott SD, Dunn B, et al. 2017 cardiovascular and stroke endpoint definitions for clinical trials. Circulation. 2018;137(9):961-72. [
DOI:10.1161/CIRCULATIONAHA.117.033502]
10. Yusuf S, Hawken S, Ôunpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. The lancet. 2004;364(9438):937-52. [
DOI:10.1016/S0140-6736(04)17018-9]
11. Albert N, Buller CE, Creager MA, Ettinger FS, Guyton RA, Ohman EM, et al. 2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults. Journal of the American College of Cardiology. 2010;56(25):e50-103.
12. Davies MJ, Woolf N, Rowles PM, Pepper J. Morphology of the endothelium over atherosclerotic plaques in human coronary arteries. British heart journal. 1988;60(6):459-64. [
DOI:10.1136/hrt.60.6.459]
13. Yew KS, Cheng E. Acute stroke diagnosis. American family physician. 2009;80(1):33.
14. Thaulow E, Erikssen J, Sandvik L, Erikssen G, Jorgensen L, Cohn PF. Initial clinical presentation of cardiac disease in asymptomatic men with silent myocardial ischemia and angiographically documented coronary artery disease (the Oslo Ischemia Study). Am J Cardiol. 1993;72(9):629-33. [
DOI:10.1016/0002-9149(93)90875-D]
15. Searls DE, Pazdera L, Korbel E, Vysata O, Caplan LR. Symptoms and signs of posterior circulation ischemia in the new England medical center posterior circulation registry. Archives of neurology. 2012;69(3):346-51. [
DOI:10.1001/archneurol.2011.2083]
16. Aggarwal S, Qamar A, Sharma V, Sharma A. Abdominal aortic aneurysm: A comprehensive review. Experimental & Clinical Cardiology. 2011;16(1):11-5.
17. Criqui MH, Langer RD, Fronek A, Feigelson HS, Klauber MR, McCann TJ, et al. Mortality over a period of 10 years in patients with peripheral arterial disease. New England Journal of Medicine. 1992;326(6):381-6. [
DOI:10.1056/NEJM199202063260605]
18. Kazeminia M, Salari N, Mohammadi M. Prevalence of cardiovascular disease in patients with type 2 diabetes mellitus in Iran: a systematic review and meta‐analysis. Journal of Diabetes Research. 2020;2020(1):3069867. [
DOI:10.1155/2020/3069867]
19. Kannel WB. Framingham study insights on diabetes and cardiovascular disease. Clinical chemistry. 2011;57(2):338-9. [
DOI:10.1373/clinchem.2010.149740]
20. Weckbach S, Findeisen HM, Schoenberg SO, Kramer H, Stark R, Clevert DA, et al. Systemic cardiovascular complications in patients with long-standing diabetes mellitus: comprehensive assessment with whole-body magnetic resonance imaging/magnetic resonance angiography. Investigative radiology. 2009;44(4):242-50. [
DOI:10.1097/RLI.0b013e31819a60d3]
21. Huxley R, Barzi F, Woodward M. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. Bmj. 2006;332(7533):73-8. [
DOI:10.1136/bmj.38678.389583.7C]
22. Bonakdaran S, Ebrahimzadeh S, Noghabi SH. Cardiovascular disease and risk factors in patients with type 2 diabetes mellitus in Mashhad, Islamic Republic of Iran. EMHJ-Eastern Mediterranean Health Journal. 2011;17(9):640-6. [
DOI:10.26719/2011.17.9.640]